Provided by Tiger Trade Technology Pte. Ltd.

VolitionRX

0.4356
-0.0137-3.05%
Volume:4.70M
Turnover:1.94M
Market Cap:5.95M
PE:-0.11
High:0.4506
Open:0.3934
Low:0.3775
Close:0.4493
52wk High:14.80
52wk Low:0.3269
Shares:13.65M
Float Shares:12.33M
Volume Ratio:0.06
T/O Rate:38.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8023
EPS(LYR):-4.3726
ROE:-730.06%
ROA:-142.94%
PB:-0.18
PE(LYR):-0.10

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)

TIPRANKS
·
Jul 08

Volitionrx Announces Availability of New Press Release

Reuters
·
Jul 07

Volitionrx Announces Data Showing the Prognostic Value of Its Nu.q® Cancer Test

THOMSON REUTERS
·
Jul 07

VolitionRx issues 333,332 shares to Lind to satisfy $416,666 note payment obligation

Reuters
·
Jun 19

VolitionRX Price Target Announced at $4.00/Share by Maxim Group

Dow Jones
·
Jun 19

VolitionRx Collaborates With Japan's Sysmex for Optimization on Platform

MT Newswires Live
·
Jun 17

VolitionRx partners with Sysmex to optimize Nu.Q NETs H3.1 assay on Sysmex platform

Reuters
·
Jun 17

VolitionRX Announces Collaboration With Sysmex

THOMSON REUTERS
·
Jun 17

VolitionRx prices public offering to raise USD 4.6 million upfront

Reuters
·
Jun 10

VolitionRX Announces Pricing of $4.6 Million Public Offering

THOMSON REUTERS
·
Jun 08

VolitionRx files patent covering Nu.Q technology for Ebola triage

TIPRANKS
·
Jun 03

VolitionRx files patent application for Nu.Q NETs Ebola triage test

Reuters
·
Jun 03

VolitionRX - Seeks Partners for Field Trials and Deployment of Lft Prototypes in Outbreak Zones

THOMSON REUTERS
·
Jun 03

VolitionRX Files New Patent Protecting Its Nu.q® Nets Test for Ebola Triage and Treatment Monitoring

THOMSON REUTERS
·
Jun 03

VolitionRx posts corporate deck outlining Nu.Q licensing strategy across cancer, sepsis and veterinary testing

Reuters
·
May 28

VolitionRx posts $1 million Q1 revenue, up 300% year over year

Reuters
·
May 27

VolitionRx submits peer-reviewed study of Nu.Q Vet feline lymphoma blood test, eyes $5 million milestone

Reuters
·
May 27

VolitionRx waives Lind note covenant breach, triggers 10% step-up charge

Reuters
·
May 23

VolitionRX Earnings Call Balances Breakthroughs and Risks

TIPRANKS
·
May 20

VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk

TIPRANKS
·
May 16